Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Precision BioSciences revenue
Precision BioSciences's revenue is $68.7 million.
What is Precision BioSciences's revenue?
- Precision BioSciences's revenue growth from 2018 to 2024 is 531.22%.
- Precision BioSciences has 100 employees, and the revenue per employee ratio is $686,960.
- Precision BioSciences's peak quarterly revenue was $68.8M in 2021(q2).
- Precision BioSciences peak revenue was $115.5M in 2021.
- Precision BioSciences annual revenue for 2023 was 48.7M, 94.15% growth from 2022.
- Precision BioSciences annual revenue for 2024 was 68.7M, 40.98% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Precision BioSciences historical revenue
Precision BioSciences's peak revenue was $115.5M in 2021. The peak quarterly revenue was $68.8M in 2021(q2).
Precision BioSciences's revenue increased from $10.9m in 2018 to $68.7M currently. That's a 531.22% change in annual revenue.
Precision BioSciences annual revenue
Precision BioSciences annual revenue over time
| Fiscal year / year | Precision BioSciences revenue |
|---|---|
| 2018 | $10.9M |
| 2019 | $22.2M |
| 2020 | $24.3M |
| 2021 | $115.5M |
| 2022 | $25.1M |
| 2023 | $48.7M |
| 2024 | $68.7M |
Rate Precision BioSciences' financial transparency
Precision BioSciences annual growth
Precision BioSciences saw the greatest revenue growth in 2021, when revenue increased by 375.72%.
Precision BioSciences had the lowest revenue growth in 2022, when revenue changed by -78.28%.
Precision BioSciences annual growth rate over time
| Year | Precision BioSciences growth |
|---|---|
| 2019 | 104%↑ |
| 2020 | 9%↑ |
| 2021 | 376%↑ |
| 2022 | -78%↓ |
| 2023 | 94%↑ |
| 2024 | 41%↑ |
Precision BioSciences quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Precision BioSciences quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | $4.9M |
| 2019 | $5.5M | $5.4M | $4.9M | $6.5M |
| 2020 | $7.0M | $1.1M | $7.4M | $8.8M |
| 2021 | $16.3M | $68.8M | $24.0M | $6.3M |
| 2022 | $3.3M | $3.8M | $7.4M | $10.6M |
| 2023 | $8.8M | $19.8M | $13.1M | $7.0M |
| 2024 | $17.6M | $49.9M | $576,000 | $638,000 |
Precision BioSciences jobs nearby
Do you work at Precision BioSciences?
Is Precision BioSciences transparent about its revenue structure?
Precision BioSciences financing
Precision BioSciences received early financing of $25.6M on 2015-05-11.
| Series | Round size | Date |
|---|---|---|
| Series A | $25.7M | 05/2015 |
| Series B | $110M | 06/2018 |
| Debt Financing | $39.5M | 03/2019 |
Precision BioSciences investors
| Investors | Security type |
|---|---|
| Eight Roads Ventures | Series A |
| The Longevity Fund | Series A |
| Baxter Ventures | Series A |
| Osage Partners | Series A |
| Ziegler Link-Age Funds | Series A |
| venBio Partners | Series A |
| F-Prime Capital | Series A |
| Amgen | Series A |
| RA Capital Management | Series A |
| BAXALTA INC | Series B |
| The Longevity Fund | Series B |
| Brace Pharma Capital | Series B |
| Gilead Sciences | Series B |
| ArrowMark Partners | Series B |
| Adage Capital Management | Series B |
| Pontifax Agtech Management LLC | Series B |
| venBio Partners | Series B |
| F-Prime Capital | Series B |
| Amgen | Series B |
| Alexandria Venture Investments | Series B |
| Cowen Healthcare Investments | Series B |
| RIDGEBACK CAPITAL MANAGEMENT | Series B |
| Agent Capital | Series B |
| Osage Partners | Series B |
| Franklin Resources | Series B |
| Duke Management Svc | Series B |
| Vivo Capital | Series B |
| OCV LLC | Series B |
| Cormorant Asset Management | Series B |
| Leerink Partners LLC | Series B |
| RA Capital Management | Series B |
| Ditch Plains Capital Management LP | Series B |
| Pontifax Agtech Management LLC | Debt Financing |
Precision BioSciences competitors
Precision BioSciences's top competitor, Arvinas Inc., earned an annual revenue of $263.4M.
Precision BioSciences's smallest competitor is Homology Medicines with revenue of $-6.7M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| REGENXBIO | - | $83.3M | 192 | - |
| Astellas Gene Therapies | - | $6.0M | 76 | - |
| Deciphera Pharmaceuticals | - | $163.4M | 200 | - |
| Poseida Therapeutics | - | $64.7M | 200 | - |
| Fibrocell Science | - | $355,000 | 12 | - |
| Homology Medicines | - | ($6.7M) | 124 | - |
| Adaptimmune | - | $178.0M | 452 | - |
| Generation Bio | - | $19.9M | 187 | - |
| Editas Medicine | - | $32.3M | 133 | - |
| Arvinas Inc. | - | $263.4M | 83 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Precision BioSciences highest paying jobs
Zippia gives an in-depth look into the details of Precision BioSciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Precision BioSciences. The employee data is based on information from people who have self-reported their past or current employments at Precision BioSciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Precision BioSciences. The data presented on this page does not represent the view of Precision BioSciences and its employees or that of Zippia.
Precision BioSciences may also be known as or be related to PRECISION BIOSCIENCES INC, Precision BioSciences, Precision BioSciences Inc, Precision BioSciences, Inc. and Precision Biosciences, Inc.